Hantaviruses are a group of viruses belonging to the Bunyaviridae family that are mainly found in rodents (such as rats, mice and voles). There are two main groups of diseases in human caused by Hantaviruses, namely Haemorrhagic Fever with Renal Syndrome (HFRS) and Hantavirus Pulmonary Syndrome (HPS), caused by hantaviruses. HFRS is caused by Old World hantaviruses present in Europe, Asia and Africa. HPS is caused by New World hantaviruses and mainly occurs in North and South America.
Mode of transmission
Hantavirus is mainly transmitted through direct contact with the faeces, saliva or urine of infected rodents or by inhalation of the virus in their aerosolised excreta.
People may also get infected via:
Human to human transmission is extremely rare.
Clinical features
In HFRS, initial symptoms begin suddenly and include intense headache, back and abdominal pain, fever, chills, nausea, and blurred vision. Other symptoms may include flushing of the face, inflammation or redness of the eyes and rash. At later stage, there may be low blood pressure and acute kidney failure. The mortality rate ranges from less than 1% to 15%.
In HPS, early symptoms include fatigue, fever and muscle ache, especially in the thighs, hips, back and sometimes shoulders. There may also be headache, dizziness, chills, nausea, vomiting, diarrhoea and abdominal pain. Respiratory symptoms such as cough and shortness of breath may appear 4 to 10 days later. A mortality rate of as high as about 40% was reported.
Incubation period
Symptoms may start to develop around 1 to 8 weeks after exposure.
Management
There is no specific treatment for hantavirus infection. Supportive care is the mainstay of management. It is important for patients to seek early medical management.
Prevention
No vaccine against Hantaviruses is available in Hong Kong at present. Rodent control is the primary strategy for preventing hantavirus infection.
To prevent the infection, the public should adopt the following measures: